Acute toxic effects of sustained-release verapamil in chronic renal failure.

Four hypertensive patients with chronic renal insufficiency or end-stage renal disease who were treated with sustained-release verapamil hydrochloride subsequently developed acute toxic effects. All four patients developed varying degrees of atrioventricular heart block, hypotension, hyperkalemia, metabolic acidosis, and hepatic dysfunction. Supportive treatment consisted of intravenous catecholamines, sodium polystyrene sulfonate, and dialysis, and all patients recovered completely without any residual hepatic or cardiac disease. Patients with renal impairment who are treated with sustained-release verapamil may accumulate verapamil or its metabolites and develop toxic side effects. We conclude that sustained-release verapamil should be used with caution in this patient population and that patients should be closely monitored for adverse cardiovascular, metabolic, and hepatic side effects.

[1]  S. Laniado,et al.  Slow-release verapamil and hyperglycemic metabolic acidosis. , 1989, Annals of internal medicine.

[2]  G. Simon,et al.  Facial Salmonella abscess. , 1989, Annals of internal medicine.

[3]  J. Burgunder,et al.  Liver injury due to verapamil. , 1988, Hepato-gastroenterology.

[4]  J. Port,et al.  Hyperkalemia after Dantrolene and Verapamil‐Dantrolene Administration in Dogs , 1988, Anesthesia and analgesia.

[5]  J. Kozlowski,et al.  Poisoning with sustained-release verapamil. , 1988, The American journal of medicine.

[6]  R. McMillan,et al.  Management of acute severe verapamil intoxication. , 1988, The Journal of emergency medicine.

[7]  B. Collier,et al.  Scintigraphic demonstration of hepatocellular damage after verapamil toxicity. , 1988, Clinical nuclear medicine.

[8]  A. McBay,et al.  Fatal verapamil poisoning. , 1987, Journal of forensic sciences.

[9]  A. Rubin,et al.  Hyperkalemia, verapamil, and dantrolene. , 1987, Anesthesiology.

[10]  D. Hare,et al.  Verapamil hepatotoxicity: a hypersensitivity reaction. , 1986, American heart journal.

[11]  P. Meredith,et al.  Verapamil pharmacokinetics and apparent hepatic and renal blood flow. , 1985, British journal of clinical pharmacology.

[12]  J. Tinker,et al.  Verapamil Worsens Rate of Development and Hemodynamic Effects of Acute Hyperkalemia in Halothane‐anesthetized Dogs: Effects of Calcium Therapy , 1984, Anesthesiology.

[13]  K. R. Heath,et al.  Hyperkalemia and Cardiovascular Collapse after Verapamil and Dantrolene Administration in Swine , 1984, Anesthesia and analgesia.

[14]  A. Conte,et al.  Liver damage from verapamil. , 1984, British medical journal.

[15]  David A. Hoffman,et al.  Profound hyperglycemia and metabolic acidosis after verapamil overdose. , 1983, Journal of the American College of Cardiology.

[16]  D. Nash,et al.  Hepatic injury possibly induced by verapamil. , 1983, JAMA.

[17]  D. Dymond,et al.  FATAL VERAPAMIL OVERDOSE , 1982, The Lancet.

[18]  B. Crump,et al.  LACK OF RESPONSE TO INTRAVENOUS CALCIUM IN SEVERE VERAPAMIL POISONING , 1982, The Lancet.

[19]  I. Wiener,et al.  Possible hepatitis from verapamil. , 1982, The New England journal of medicine.

[20]  D. Weiner,et al.  Hepatotoxicity due to treatment with verapamil. , 1981, Annals of internal medicine.

[21]  E. Waris,et al.  Three cases of severe verapamil poisoning. , 1981, International journal of cardiology.

[22]  F. Moroni,et al.  Calcium gluconate and hypertonic sodium chloride in a case of massive verapamil poisoning. , 1980, Clinical toxicology.

[23]  M. Soler,et al.  Acute intoxication with verapamil. , 1979, Chest.

[24]  Orlando A. Silva,et al.  Verapamil Acute Self-Poisoning , 1979 .

[25]  R. A. Ammon,et al.  Glucose-induced hyperkalemia with normal aldosterone levels. Studies in a patient with diabetes mellitus. , 1978, Annals of internal medicine.

[26]  U. de Faire,et al.  Attempted suicide with verapamil. , 1977, European journal of cardiology.

[27]  M. Eichelbaum,et al.  Physiological disposition of verapamil in man. , 1976, Cardiovascular research.

[28]  E. Obberghen,et al.  Calcium antagonists and islet function. I. Inhibition of insulin release by verapamil. , 1975 .

[29]  M. Rosen,et al.  Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil. , 1975, American heart journal.

[30]  V. Rønnov-Jessen,et al.  Hepatotoxicity due to treatment with papaverine. Report of four cases. , 1969, The New England journal of medicine.